The Prognostic Significance of Peritoneal Seeding and Size of Postsurgical Residual in Patients with Stage III Epithelial Ovarian Cancer Treated with Surgery, Chemotherapy, and High-Dose Radiotherapy
- 1 September 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 74 (3) , 400-407
- https://doi.org/10.1006/gyno.1999.5477
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Consolidation Radiotherapy after Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian CancerGynecologic Oncology, 1999
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian CancerGynecologic Oncology, 1995
- Cellular DNA content and survival in advanced ovarian carcinomaCancer, 1994
- Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapyAnnals of Oncology, 1993
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.Journal of Clinical Oncology, 1991
- The treatment of advanced ovarian carcinoma (I): Clinical variables associated with prognosisGynecologic Oncology, 1988
- Advanced epithelial ovarian cancer: Toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperationGynecologic Oncology, 1986
- Prognostic factors in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958